SBIR-STTR Award

Freeze Dried Plasma for Canines
Award last edited on: 5/26/2023

Sponsored Program
SBIR
Awarding Agency
DOD : SOCOM
Total Award Amount
$3,556,745
Award Phase
2
Solicitation Topic Code
SOCOM163-007
Principal Investigator
Michael Cushman

Company Information

Mantel Technologies

2401 Research Boulevard Suite 204
Fort Collins, CO 80526
   (970) 631-6917
   mc@manteltechnologies.com
   www.manteltechnologies.com
Location: Multiple
Congr. District: 04
County: Larimer

Phase I

Contract Number: H92222-17-P-0009
Start Date: 1/17/2017    Completed: 7/10/2017
Phase I year
2017
Phase I Amount
$144,517
Hemorrhage is the leading cause of preventable death in combat, and damage control resuscitation (DCR) research has shown that plasma is a superior resuscitation fluid for severely injured, bleeding canine casualties. However, cold chain requirements make managing fresh frozen plasma (FFP) supply logistics difficult in austere environments. Limited supplies of freeze dried plasma (FDP) are currently available to the US military today through an agreement with the French Military for human use. However, there is no capability to provide Military Working Dogs (MWD) with any blood products. To meet the needs of the modern MWD, lighter weight, rugged, compressible, and easy to use FDP is required. This project will include evaluation and adaptation of a rugged, collapsible, and light weight FDP bag created for human FDP, the optimization of FDP techniques used for human FDP to canine plasma and the characterization of the effects of lyophilization on canine plasma from MWD representative breeds, German Shepherd Dogs and Belgian Malinois.

Phase II

Contract Number: H92222-18-C-0015
Start Date: 2/5/2018    Completed: 8/2/2019
Phase II year
2018
(last award dollars: 2021)
Phase II Amount
$3,412,228

Hemorrhage is the leading cause of preventable death in combat, and damage control resuscitation (DCR) research has shown that plasma is a superior resuscitation fluid for severely injured, bleeding canine casualties.However, cold chain requirements make managing fresh frozen plasma (FFP) supply logistics difficult in austere environments.Limited supplies of pathogen reduced freeze-dried plasma (FDP) are currently available to the US military today through an agreement with the French Military for human use.However, there is no capability to provide Military Working Dogs (MWD) with any blood products. In this Phase II SBIR, Mantel Technologies proposes to continue the development of an FDP process and packaging solution for military working dogs and other canines. This effort will expand upon Phase I data to broaden repeatability, assess safety via a low risk study, and develop a user-focused canine FDP kit for field use.